Bryant Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bryant Wang has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Afua B. Faibille
High Point University
1 shared publication - Amy E. Moritz
Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 35 Convent Drive, Bethesda, MD 20892, USA
1 shared publication - Ashley N. Nilson
NINDS/NIH
1 shared publication - Bailey Balouch
Division of Otolaryngology—Head and Neck Surgery Cooper University Hospital Camden New Jersey USA
1 shared publication - Barbara S. Slusher
Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
1 shared publication - Chae Bin Lee
Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, 855 N. Wolfe Street, Baltimore, Maryland 21205, United States
1 shared publication
Latest Publications
- Open Access
- 8 October 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (5)
Concomitant Temporal and Facial Bone Fractures: Patterns, Outcomes, and Cushion Effect Hypothesis
Objective(s): To investigate injury patterns, clinical features and outcomes in patients with concomitant temporal bone fractures (TBFs) and facial bone fractures (FBFs). To evaluate these findings in the context of the cushion effect hypothesis. Methods: Retrospective cohort analysis of patients with radiographically confirmed TBFs at a tertiary care medical center. Patients were grouped by presence or absence of concomitant FBFs. Characteristics including trauma mechanism, findings on evaluation, and TBF complications were compared at presentation and follow‐up. Multivariate logistic regression analysis was performed controlling for age, gender, and trauma mechanism. Results: Of 219 TBF patients from February 2011 to November 2023, 61 had concomitant FBFs. Motor vehicle collision was the most common trauma mechanism in the TBF/FBF group (50.82%) and fall was predominant in the TBF alone group (43.67%). Concomitant FBFs were associated with a reduced rate of hemotympanum (OR = 0.338, p = 0.001) and subjective hearing loss on follow‐up evaluation (OR = 0.284, p = 0.001). Specifically, mandibular fractures in the TBF/FBF cohort were associated with a decreased risk of intracranial hemorrhage (ICH) (OR = 0.127, p = 0.005). No differences were observed for other TBF complications. Conclusion: TBF patients presenting with concomitant FBFs sustained more severe initial trauma, but had lower rates of hemotympanum and hearing loss. Mandibular fractures in the TBF/FBF cohort were independently associated with lower rates of ICH. These findings are compatible with the cushion effect hypothesis; however, causality cannot be inferred. Further prospective and biomechanical studies are warranted to clarify these relationships. Level of Evidence: 4.
- 8 October 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (5)
Open AccessConcomitant Temporal and Facial Bone Fractures: Patterns, Outcomes, and Cushion Effect Hypothesis
Objective(s): To investigate injury patterns, clinical features and outcomes in patients with concomitant temporal bone fractures (TBFs) and facial bone fractures (FBFs). To evaluate these findings in the context of the cushion effect hypothesis. Methods: Retrospective cohort analysis of patients with radiographically confirmed TBFs at a tertiary care medical center. Patients were grouped by presence or absence of concomitant FBFs. Characteristics including trauma mechanism, findings on evaluation, and TBF complications were compared at presentation and follow‐up. Multivariate logistic regression analysis was performed controlling for age, gender, and trauma mechanism. Results: Of 219 TBF patients from February 2011 to November 2023, 61 had concomitant FBFs. Motor vehicle collision was the most common trauma mechanism in the TBF/FBF group (50.82%) and fall was predominant in the TBF alone group (43.67%). Concomitant FBFs were associated with a reduced rate of hemotympanum (OR = 0.338, p = 0.001) and subjective hearing loss on follow‐up evaluation (OR = 0.284, p = 0.001). Specifically, mandibular fractures in the TBF/FBF cohort were associated with a decreased risk of intracranial hemorrhage (ICH) (OR = 0.127, p = 0.005). No differences were observed for other TBF complications. Conclusion: TBF patients presenting with concomitant FBFs sustained more severe initial trauma, but had lower rates of hemotympanum and hearing loss. Mandibular fractures in the TBF/FBF cohort were independently associated with lower rates of ICH. These findings are compatible with the cushion effect hypothesis; however, causality cannot be inferred. Further prospective and biomechanical studies are warranted to clarify these relationships. Level of Evidence: 4.
- Open Access
- 15 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics
Dopamine D4 receptor (D4R) signaling affects decision-making, memory formation, cognition, and attention. Previously developed D4R-selective ligands were metabolically unstable in vivo due to amide bond linker hydrolysis. In this study, analog compounds were synthesized using click chemistry, bioisosterically replacing amides with a 1,2,3-triazole linker. Herein, we report 1,2,3-triazole analogs maintained high D4R affinity and subtype selectivity while retaining their functional activity. Using rat and human liver microsomes to evaluate phase I metabolism, we determined that amide ligands were more metabolically unstable in rat microsomes, and the triazole substitutions enhanced compound stability. Four compounds were evaluated in rat pharmacokinetics studies. In particular, 17 (antagonist) and 18 (low-efficacy partial agonist) had desirable results in plasma half-life and brain exposure measures. These new analogs are suitable for behavioral studies in rats and represent improved molecular tools to further explore D4R signaling in rodent models.
- 15 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessBioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics
Dopamine D4 receptor (D4R) signaling affects decision-making, memory formation, cognition, and attention. Previously developed D4R-selective ligands were metabolically unstable in vivo due to amide bond linker hydrolysis. In this study, analog compounds were synthesized using click chemistry, bioisosterically replacing amides with a 1,2,3-triazole linker. Herein, we report 1,2,3-triazole analogs maintained high D4R affinity and subtype selectivity while retaining their functional activity. Using rat and human liver microsomes to evaluate phase I metabolism, we determined that amide ligands were more metabolically unstable in rat microsomes, and the triazole substitutions enhanced compound stability. Four compounds were evaluated in rat pharmacokinetics studies. In particular, 17 (antagonist) and 18 (low-efficacy partial agonist) had desirable results in plasma half-life and brain exposure measures. These new analogs are suitable for behavioral studies in rats and represent improved molecular tools to further explore D4R signaling in rodent models.